Metabolic Surgery Offers Significant Long-Term Benefits for Patients with MASH-Related Cirrhosis: Study Finds Medha Baranwal23 Feb 2025 8:30 PM ISTUSA: A recent study highlights the potential benefits of metabolic surgery in improving liver outcomes among patients with compensated cirrhosis due...
Weight-Loss Surgery May Reduce Liver Disease Complications in Obese Cirrhosis Patients: Study Finds Dr. Bhumika Maikhuri30 Jan 2025 8:30 AM ISTA Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly...
Young Adulthood Obesity Linked to Liver Disease Risk, But Weight Loss Reverses Effects, Study Finds Medha Baranwal5 Dec 2024 8:15 PM ISTNetherlands: Stable or newly developed obesity during young adulthood significantly increases the risk of metabolic dysfunction-associated steatotic...
Combining SGLT2 Inhibitors and Pioglitazone May Reduce Risk of MASH in Type 2 Diabetes, Study Finds Medha Baranwal16 Nov 2024 8:15 AM ISTChina: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors (SGLT2i) and pioglitazone...
